Frequently Asked Questions

For any durable medical equipment supplier, the sight of a thick envelope from a government contractor demanding medical records is a cause for concern. But not all audits are created equal. While many are familiar with Recovery Audit Contractors (RACs), a letter from a Unified Program Integrity Contractor (UPIC) signals a much more serious and potentially threatening investigation. Understanding the unique role and aggressive tactics of UPICs is crucial for survival in today's enforcement-heavy climate.

The UPIC program divides the country into five jurisdictions, each managed by a specific contractor tasked with overseeing program integrity. The Northeastern and Midwestern jurisdictions are both managed by CoventBridge Group. The Western and Southern jurisdictions are handled by Qlarant. For many DME providers, the most significant contractor is Safeguard Services (SGS), which holds the contract for the national jurisdiction specifically covering Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS). Knowing which UPIC operates in your region is important, as it is the entity that will initiate an investigation if your billing data is flagged.

What truly distinguishes a UPIC audit is the power wielded by the contractor. Beyond standard post-payment reviews where they can demand repayment for claims already paid, UPICs have the authority to place a supplier on pre-payment review. This means every claim submitted must be manually reviewed and approved before any payment is made. Even more devastating is their ability to recommend a full payment suspension to CMS. If a UPIC finds credible evidence of fraud, it can request that all Medicare payments to the supplier be halted. This action can starve a business of its cash flow, effectively shutting down operations long before any formal finding of wrongdoing is finalized.

The audit process itself is an intense, high-pressure event. A UPIC will typically demand a substantial number of patient files with a very short turnaround time. The burden of proof falls entirely on the DME supplier to produce flawless documentation for every claim under review. This includes the original physician’s order, detailed clinical notes establishing medical necessity, and indisputable proof of delivery. Any missing or incomplete document can result in a claim denial. If the auditors find a high error rate in the initial sample of claims, they will often extrapolate that error rate across all claims billed over a period of years, leading to a massive and potentially business-ending recoupment demand.

The legal and financial stakes of a UPIC audit are incredibly high, and a swift, strategic response is paramount. Health Law Alliance can assist DME suppliers with navigating every stage of a UPIC audit, from the initial records request to appealing adverse findings. Please schedule a free consultation today to protect your business.

MORE ARTICLES BY CATEGORY

Get a Free Case REVIEW

100% Confidential & Secure. Your details are safe with us.

We'll speak soon!

In the meantime, why not find out more about us or visit our blog.

Alternatively, give us a call at (800) 345 - 4125

Oops! Something went wrong while submitting the form.

Guidance for New Entrants on Navigating PBM Audit Complexities

New pharmacy owners face complex PBM audit requirements that demand strict documentation, accurate claims, and ongoing compliance. Establishing strong recordkeeping systems and proactive audit readiness can help prevent costly recoupments and protect long-term network participation.

Read More >>

How Pharmacies Can Challenge Unfair PBM Audit Findings

PBM audits can leave pharmacies facing exaggerated findings, steep recoupments, and even network termination. With the right strategies and legal support, pharmacies can successfully challenge unfair results and protect their business.

Read More >>

Top Red Flags That May Trigger a PBM Audit

PBM audits can be disruptive, costly, and often triggered by high prescription volumes, dispensing irregularities, or claim activity. Pharmacies can reduce risks through strong documentation, compliance, and legal support to challenge unfair findings and protect network status.

Read More >>

Approaching the Telehealth Policy Cliff: Medicare Telehealth Flexibilities to Expire Next Week

Without further congressional action, COVID-19 era telehealth flexibilities are set to expire on September 30, 2025. Read more to learn about what’s set to change and key guidance for telehealth providers to prepare to adapt to pre-pandemic coverage rules.

Read More >>